Item 9 Labs Corp. is a holding company, investing in cannabis and cannabis-related businesses. Its subsidiaries compete in three different market segments: (1) producing cannabis and cannabis-derived products and technologies through its Item 9 Labs brand, which is currently distributed throughout the State of Arizona in licensed medical and adult-use dispensaries; (2) sell medical and adult-use cannabis dispensary franchises under its franchise brand “Unity Rd.”; and (3) will operate medical and adult-use cannabis dispensaries under its retail franchise “Unity Rd.”
Company profile
Ticker
INLB
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
DENTSPLY Sirona • Envista • ZimVie • SmileDirectClub • Sonendo • Biolase • Remedent • Costas • Bruush Oral Care • Capstone Dental Pubco ...
Former names
AIRWARE LABS CORP., CROWN DYNAMICS CORP
SEC CIK
Corporate docs
IRS number
980665018
Latest filings (excl ownership)
10-Q
2023 Q3
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
8-K
Bankruptcy or Receivership
20 Jul 23
8-K
Departure of Directors or Certain Officers
7 Jul 23
8-K
Departure of Directors or Certain Officers
27 Jun 23
8-K
Termination of a Material Definitive Agreement
6 Jun 23
10-Q
2023 Q2
Quarterly report
22 May 23
8-K
Departure of Directors or Certain Officers
22 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
8-K
Departure of Directors or Certain Officers
12 May 23
Latest ownership filings
SC 13G
Clearthink Capital Partners, LLC
21 Feb 24
3
Eric Kutscher
10 Jan 22
3
Lawrence X. Taylor III
10 Jan 22
3
Douglas P Bowden
5 Apr 21
3
MICHAEL P KESKEY
13 Aug 20
4
Bryce Skalla
11 Sep 19
4
Andrew Poirier
10 Sep 19
4
Patrick Sean Dugan
10 Sep 19
3
Ronald L. Jr. Miller
29 Aug 19
3
Bryce Skalla
29 Aug 19
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 22 | Sep 21 | Sep 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 183.43 k | 183.43 k | 183.43 k | 183.43 k | 183.43 k | 183.43 k |
Cash burn (monthly) | (no burn) | 22.81 k | 988.68 k | 1.68 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 225.71 k | 9.78 mm | 16.62 mm | n/a | n/a |
Cash remaining | n/a | -42.28 k | -9.60 mm | -16.44 mm | n/a | n/a |
Runway (months of cash) | n/a | -1.9 | -9.7 | -9.8 | n/a | n/a |